Product Overview

Evokalm 200mg Tablets are a medication used to treat various mental health conditions, such as schizophrenia, bipolar disorder, and major depressive disorder. These tablets contain Quetiapine as the active ingredient, which helps to regulate certain chemicals in the brain that may be imbalanced in people with these conditions.

Key Benefits

• Treats symptoms of schizophrenia, bipolar disorder, and major depressive disorder
• Regulates chemicals in the brain to improve mood and behavior
• Helps reduce hallucinations, delusions, and mood swings
• Can improve sleep, appetite, and energy levels in individuals with mental health disorders

How It Works

Quetiapine, the active ingredient in Evokalm 200mg Tablets, works by blocking the activity of certain neurotransmitters in the brain, such as dopamine and serotonin. By doing so, it helps to regulate the communication between nerve cells and improve the symptoms associated with mental health conditions.

Directions for Use

• Take Evokalm 200mg Tablets as prescribed by your healthcare provider.
• Swallow the tablet whole with a glass of water.
• It is usually taken once daily in the evening with or without food.
• Do not crush, chew, or break the tablet before taking it.

Precautions

• Do not suddenly stop taking this medication without consulting your doctor, as it may cause withdrawal symptoms.
• Inform your healthcare provider about any allergies or medical conditions you have before starting this medication.
• Avoid consuming alcohol while taking Evokalm 200mg Tablets, as it may increase the risk of side effects.

Storage Instructions

Store Evokalm 200mg Tablets at room temperature away from moisture and heat. Keep the tablets in their original packaging and out of reach of children and pets.

Manufacturer Information

Evokalm 200mg Tablets are manufactured by Pharmevo, a reputable pharmaceutical company known for producing high-quality medications for various health conditions. Pharmevo is committed to providing safe and effective treatment options for patients worldwide.